Partner Ed Wallace Appointed to Executive Committee in Essure® Product Cases in California JCCP
Wexler Wallace partner Ed Wallace has been appointed to the Plaintiffs’ Executive Committee for the Coordinated Essure® litigation in California against Bayer Corp. The appointment was made by Judge Winifred Y. Smith in the Superior Court of California, County of Alameda as part of a Judicial Council Coordinated Proceeding (JCCP) assigned to Judge Smith. As a member of the Executive Committee, Ed joined fellow Committee members Erin Copeland of Fibich Leebron Copeland Briggs & Josephson; Kim Dougherty of Janet, Jenner & Suggs, LLC; M. Elizabeth Graham of Grant & Eisenhofer P.A.; and Fidelma Fitzpatrick of Motley Rice LLC, who has been named Lead Counsel of the Executive Committee. They are responsible for coordinating the activities of Plaintiffs during all pretrial proceedings.
Essure® is marketed as the only permanent birth control device with a non-surgical procedure. The device consists of coils that are made from nickel and titanium which are implanted into a woman’s fallopian tubes to block sperm from reaching the egg, thus preventing pregnancy.
The Food and Drug Administration (FDA) have announced that over 9,000 women from across the U.S. have voluntarily reported serious and permanent injuries that they believe stem from their Essure® implant. Reported Essure® complications include migration of the device which can cause perforation or tears to the pelvic organs, severe pain, life-threatening ectopic pregnancies, fetal death, and additional surgeries (including total hysterectomies to remove the device and repair internal organs)In October 2016, the FDA required Bayer Corp. to add a black box warning (the FDA’s highest warning level) to Essure® indicating that the product may cause serious injuries or death.
To read the appointment order in full, click here.